Implantable medical lead
The use of a delivery catheter with visual markers and curvature, along with strain relief features on the implantable lead, addresses the challenges of precise placement and secure fixation in complex anatomical locations by enhancing visibility and reducing tensile forces, resulting in improved implantation efficiency.
Patent Information
- Application Number
- PCT/US2026/028421
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2025-05-15
- Filing Date
- 2026-05-15
- Publication Date
- 2026-11-19
AI Technical Summary
Existing implantable medical leads face challenges in precise placement and secure fixation to target tissues, particularly in complex anatomical locations like the pericardial cavity, due to difficulties in visualization and potential unintended removal caused by tensile forces.
The implementation of a delivery catheter with distinct visual markers and a curvature design, combined with an implantable lead featuring strain relief features, allows for controlled advancement and secure fixation to target tissues by enhancing visibility and reducing tensile forces.
This approach facilitates precise alignment and secure implantation of the medical lead, reducing the need for complex visualization techniques and minimizing the risk of unintended removal, thereby improving the implantation process.
Smart Images

Figure US2026028421_19112026_PF_FP_ABST
Abstract
Description
Docket No: A0013244W001 / 2222-639W001IMPLANTABLE MEDICAL LEADCROSS-REFERENCE TO RELATED APPLICATIONS
[0001] The present application claims priority to and the benefit of U.S. Provisional Application Serial No. 63 / 806,253, filed on May 15, 2025, which is incorporated herein by reference in its entirety.TECHNICAL FIELD
[0002] This disclosure is related to medical devices such as implantable medical leads.BACKGROUND
[0003] Various types of implantable medical leads have been implanted for treating or monitoring one or more conditions of a patient. Such implantable medical leads may be adapted to allow medical devices to monitor or treat conditions or functions relating to heart, muscle, nerve, brain, stomach, endocrine organs or other organs and their related functions. Implantable medical leads include electrodes and / or other elements for physiological sensing and / or therapy delivery. Implantable medical leads allow the sensing / therapy elements to be positioned at one or more target locations for those functions, while the medical devices electrically coupled to those elements via the leads are at different locations.
[0004] Implantable medical leads, e.g., distal portions of elongated implantable medical leads, may be implanted at target locations selected to detect a physiological condition of the patient and / or deliver one or more therapies. For example, implantable medical leads may be delivered to locations within a pericardial cavity of the patient to sense cardiac signals and deliver pacing or antitachyarrhythmia shock therapy to cardiac tissue (e.g., an epicardium) of the patient from a medical device coupled to the lead. Implantable medical leads may include fixation components to secure a distal end of the lead at the target location.SUMMARY
[0005] An implantable medical lead comprises includes a lead body supporting a fixation element (e.g., a helix) extending distal to the lead body. The implantable lead may be affixed to a target tissue of a patient and may deliver a medical stimulation therapy (e.g., a pacing signal or a shock signal) to the target tissue from an external signal generator to the target tissue.
[0006] This disclosure is directed to an example medical device system including an implantable lead and a delivery catheter configured to deliver a distal portion of the implantableDocket No: A0013244W001 / 2222-639W001 lead to target tissue of the patient. The target tissue may include, but is not limited to, cardiac tissue of the heart of the patient. In some examples, the target tissue may be a portion of the epicardium within a pericardial cavity of the patient.
[0007] The implantable lead may include a plurality of lead markers on the lead body and the delivery catheter may include one or more catheter markers on the catheter body. The lead marker(s) and catheter marker(s) may be visually identifiable and distinct. A clinician may align lead marker(s) and catheter marker(s) to control movement of the implantable lead within the delivery catheter (e.g., to controllably advance or retract the fixation element on the implantable lead into or out of the delivery catheter). The lead marker(s) and catheter marker(s) may be visually identifiable and distinct through one or more layers of patient tissue (e.g., through the pericardium of the patient tissue), e.g., allowing the clinician to visually align the lead marker(s) and the catheter marker(s).
[0008] The implantable lead may define one or more strain relief features. The strain relief feature(s) may reduce tensile forces on implantable lead after implantation and may inhibit unintended removal of the implantable lead from the target tissue. The strain relief feature(s) may urge fixation element of the implantable lead distally and may improve fixation of implantable lead in the target tissue.
[0009] The delivery catheter may define a curvature at or around a distal portion of the catheter body. The curvature may allow for implantation of implantable lead into the target tissue at an angle, e.g., thereby inhibiting an amount of space required for implantation of the implantable lead. The curvature may allow the catheter body to interface with tissue of the patient (e.g., with pericardium of the patient) to urge a distal end of the catheter body towards the target tissue (e.g., towards the epicardium of the patient), e.g., thereby improving fixation of the implantable lead within the target tissue.
[0010] In some examples, this disclosure is directed to a system comprising: a delivery catheter comprising: an elongated tube, the elongated tube defining an inner lumen extending along a longitudinal length of the elongated tube to a catheter distal end of the elongated tube; and a catheter marker disposed at a longitudinal position of the elongated tube; and an implantable lead configured to be disposed within the delivery catheter, the implantable lead comprising: an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient; a first lead marker disposed at a first longitudinal location of the elongated body; and a second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location being proximal to the first longitudinal location, wherein the catheter marker, the first lead marker, andDocket No: A0013244W001 / 2222-639W001 the second lead marker are configured to be disposed within a body of a patient during implantation of the implantable lead in the body of the patient, wherein when the first lead marker is longitudinally aligned with the catheter marker, the fixation element is disposed within the inner lumen of the elongated tube of the delivery catheter, and wherein when the second lead marker is longitudinally aligned with the catheter marker, the fixation element extends distally past the catheter distal end of the elongated tube.
[0011] In some examples, this disclosure is directed to a delivery catheter comprising: an elongated tube comprising: a proximal portion extending along a longitudinal axis; a distal portion extending radially away from the longitudinal axis; and a curved portion connecting the proximal portion to the distal portion; and one or more catheter markers disposed at a longitudinal position of the elongated tube, wherein the curved portion defines a curvature in the elongated tube along a reference plane extending along the longitudinal axis.
[0012] In some examples, this disclosure is directed to an implantable lead comprising: an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient; a first lead marker disposed at a first longitudinal location of the elongated body; and a second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location being proximal to the first location along the longitudinal axis, wherein the elongated body defines one or more strain relief features along a longitudinal length of the elongated body, wherein the first lead marker is configured to indicate, when aligned with a catheter marker on a delivery catheter, that the fixation element is disposed within the delivery catheter, and wherein the second lead marker is configured to indicate, when aligned with the catheter marker, that at least the fixation element of the implantable lead protrudes from a distal end of the delivery catheter.
[0013] In some examples, this disclosure is directed to a method comprising: advancing a medical device system to a target location within a patient, the medical device system comprising: a delivery catheter comprising: an elongated tube, the elongated tube defining an inner lumen extending along a longitudinal length of the elongated tube to a catheter distal end of the elongated tube; and a catheter marker disposed at a longitudinal position of the elongated tube; and an implantable lead configured disposed within the inner lumen, the implantable lead comprising: an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient; a first lead marker disposed at a first longitudinal location of the elongated body; and a second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location beingDocket No: A0013244W001 / 2222-639W001 proximal to the first longitudinal location; placing the catheter distal end of the elongated tube in contact with a tissue of the patient, wherein during placement of the catheter distal end, the first lead marker is aligned with the catheter marker to retain the fixation element within the inner lumen of the elongated tube; advancing the implantable lead within the inner lumen until the second lead marker is aligned with the catheter marker to place the fixation element in contact with the tissue of the patient; affixing the fixation element of the implantable lead to the tissue of the patient; and retracting the delivery catheter from within the patient.
[0014] The details of one or more examples are set forth in the accompanying drawings and the description below. Other features, objects, and advantages will be apparent from the description and drawings, and from the claims.BRIEF DESCRIPTION OF DRAWINGS
[0015] FIG. 1 A is a conceptual diagram illustrating an example medical device system in a retracted configuration.
[0016] FIG. IB is a conceptual diagram illustrating the example medical device system of FIG. 1 A in an advanced configuration.
[0017] FIG. 2 is a conceptual diagram illustrating an example implantable lead of the medical device system of FIG. 1A.
[0018] FIG. 3 is a conceptual diagram illustrating another example of the implantable lead of the medical device system of FIG. 1A.
[0019] FIG. 4A is a conceptual diagram illustrating an example delivery catheter of the example medical device system of FIG. 1A.
[0020] FIG. 4B is a conceptual diagram illustrating another example delivery catheter of the example medical device system of FIG. 1A.
[0021] FIG. 5A is a conceptual diagram illustrating insertion of the medical device system of any of FIGS. 1A-4 within a patient.
[0022] FIG. 5B is a conceptual diagram illustrating implantation of the implantable lead of the medical device system of any of FIGS. 1A-4 within the patient.
[0023] FIG. 6 is a flow chart illustrating an example process of implanting an implantable lead using the medical device system of any of FIGS. 1-5B.DETAILED DESCRIPTION
[0024] The disclosure describes a medical device system including a delivery catheter and an implantable medical lead configured to deliver pacing or shock therapy to a heart of a patient.Docket No: A0013244W001 / 2222-639W001 The delivery catheter may be configured to deliver the implantable medical lead to a location at or around a target tissue of the patient. The implantable medical lead may include a fixation element at or around a distal end of the lead body and may be configured to be affixed to the target tissue via the fixation element.
[0025] The delivery catheter may include an elongated tube (e.g., alternatively referred to herein as a “catheter body”) defining an inner lumen. The inner lumen may be sized to retain the implantable lead. A distal portion of delivery catheter may be curved or may define one or more curved portions. The curved portion(s) and / or curvature may allow a catheter distal end of the delivery catheter to contact the target tissue at an angle and for implantation of the implantable lead into the target tissue at the angle. The angled implantation may eliminate a need to position the fixation element of the implantable lead to be orthogonal to the tissue surface during implantation, e.g., thereby reducing a volume around the target tissue required to implant the implantable lead and / or increasing a number of possible implantation sites within the patient.
[0026] The delivery catheter may be at least partially transparent and may include one or more catheter markers on the elongated tube. The implantable lead may include one or more lead markers (e.g., at least a first lead marker and a second lead marker proximal to the first lead marker) on an elongated body (alternatively referred to herein as “lead body”) of the implantable lead. The clinician may align catheter marker(s) with the lead marker(s) (e.g., with the first lead marker) to fully retain the implantable lead within the delivery catheter (e.g., during advancement of medical device system to the target tissue). The clinician may align catheter marker(s) with other lead marker(s) (e.g., with the second lead marker) to advance implantable lead out of the delivery catheter and allow for fixation of the implantable lead to the target tissue. The lead marker(s) and catheter marker(s) may be visually identifiable and distinguishable by a clinician and may be seen through one or more layers of patient tissue. For example, the clinician may visually identify and align the lead marker(s) and the catheter marker(s) through a pericardium of the patient. The ease of visualization of the lead marker(s) and catheter marker(s) may simplify the implantation process and may allow for implantation via the use of direct visualization tools (e.g., via a thoracoscope) over more complex visualization techniques (e.g., fluoroscopy).
[0027] In some examples, the implantable lead includes a third lead marker at or around a proximal end of the implantable lead and the delivery catheter includes a proximal catheter marker at or around the proximal end of the elongated tube. The clinician may determine a relative position of the implantable lead within the delivery catheter via one or more corresponding pairs of lead markers and catheter markers.
[0028] Each corresponding pair of lead markers and catheter markers may present the same or substantially similar information on the position of the implantable lead within the deliveryDocket No: A0013244W001 / 2222-639W001 catheter. For example, the clinician may determine the position of the implantable lead within the delivery catheter (e.g., that a fixation element of the implantable lead is aligned with a distal end of the elongated tube) based on one or more of: an alignment between the first lead marker and a first catheter marker, an alignment between the second lead marker and a second catheter marker proximal to the first catheter marker, or an alignment between the third lead marker and the proximal catheter marker. In some examples, one or more pairs of lead markers and catheter markers may be obscured (e.g., by patient tissue). For example, the first lead marker and the first catheter marker may be obscured by patient tissue. In such examples, the clinician may determine the position of the implantable lead and monitor fixation of the implantable lead via the second lead marker and the second catheter marker and / or via the third lead marker and the proximal catheter marker. In some examples, the clinician may determine the position of the implantable lead and monitor fixation of the implantable lead using a portion of the medical device system outside of the patient body (e.g., via the third lead marker and the proximal catheter marker).
[0029] The implantable lead may define one or more strain relief features along the length of lead body. The one or more strain relief features may create slack along the length of the lead body and may reduce tensile forces on the implantable lead (e.g., on the fixation element) after implantation of the implantable lead. The reduction in the tensile forces may inhibit unintended removal of the implantable lead from the target tissue. The one or more strain relief features may also urge the fixation element distally and improve fixation of the implantable lead to the target tissue. The one or more strain relief features may include, but are not limited to, undulation(s) or loop(s) along the lead body.
[0030] FIG. 1A is a conceptual diagram illustrating an example medical device system 100 in a retracted configuration. Medical device system 100 (alternatively referred to herein as “system 100”) may include a delivery catheter 102 (alternatively referred to herein as “delivery sheath 102”) and an implantable lead 104 (alternatively referred to herein as “lead 104”) disposed within an inner lumen 111 of delivery catheter 102. When system 100 is in the retracted configuration, a distal end of lead 104 may be disposed within inner lumen 111 of delivery catheter 102.
[0031] Delivery catheter 102 may include a handle 106 and an elongated tube 110 (alternatively referred to herein as “catheter body 110”) extending distally from handle 106. Handle 106 may be assembled and / or molded around elongated tube 110. Elongated tube 110 may define an inner lumen 111. Inner lumen 111 may be extending from a proximal opening 108 to a catheter distal end 116. Handle 106 may define a port or opening to allow access to inner lumen 111. The port or opening may define proximal opening 108. Handle 106 may include one or more valves at or around proximal opening 108, e.g., to inhibit unintended flow of fluid into or out of inner lumen 111 of elongated tube 110.Docket No: A0013244W001 / 2222-639W001
[0032] Elongated tube 110 may extend from proximal opening 108 to catheter distal end 116. Catheter distal end 116 may define an atraumatic tip. Elongated tube 110 may define a distal opening to inner lumen 111 at or around catheter distal end 116. Elongated tube 110 may be at least partially or entirely transparent. Elongated tube 110 may be formed from a biocompatible polymer such as, but is not limited to, polyether block amide such as Pebax®. Elongated tube 110 may include a plurality of catheter markers 118A - 118N (collectively referred to herein as “catheter markers 118”) disposed on elongated tube 110. Each of catheter markers 118 may be visually identifiable. Different catheter markers 118 may be visually distinctive. One or more catheter markers (e.g., catheter marker 118N) may be positioned at or around a proximal end of elongated tube 110 (e.g., on, distal to, or proximal to handle 106). Catheter marker 118N may be alternatively referred to herein as “proximal catheter marker 118N” or “third catheter marker 118N”. When elongated tube 110 is inserted into a patient body, proximal catheter marker 118N may be positioned outside of the patient body.
[0033] Elongated tube 110 may define a proximal portion 114B, a distal portion 114A, and a curve portion 112 connecting proximal portion 114B to distal portion 114A. In some examples, as illustrated in FIG. 1 A, proximal portion 114B and distal portion 114A each define a straight section of elongated tube 110 and curved portion 112 defines a curvature. In some examples, elongated tube 110 defines a curvature from a distal end of proximal portion 114B to catheter distal end 116. Elongated tube 110 may define one curved portion 112 or two or more curved portions 112. Distal portion 114A, curved portion 112, and proximal portion 114B may extend along a same reference plane. Distal portion 114A may extend distally from and radially away a central axis of proximal portion 114B along a same reference plane as proximal portion 114B. For example, elongated tube 110 may define the curvature in a first reference plane but may not define any curvatures in a second reference plane orthogonal to the first reference plane. In such examples, elongated tube 110 may define a reduced profile e.g., a reduced width) along the second reference plane than along the first reference plane.
[0034] Catheter markers 118 may be visually identifiable and distinguishable, e.g., through a layer of tissue of a patient. For example, a clinician may be able to visually differentiate different catheter markers 118, e.g., through a pericardium of the patient. The layer of tissue may be translucent. A first catheter marker 118A may be disposed proximal to catheter distal end 116 of elongated tube 110. Other catheter markers (e.g., catheter markers 118B-N) may be disposed proximal of first catheter marker 118A. For example, second catheter marker 118B may be proximal to first catheter marker 118A. Longitudinally adjacent catheter markers 118 may be equally spaced along elongated tube 110.Docket No: A0013244W001 / 2222-639W001
[0035] Lead 104 may be configured to be retained within inner lumen 111 of elongated body 110. Lead 104 may be inserted into inner lumen 111 of elongated tube 110 via proximal opening 108. An inner surface of elongated tube 110 defining inner lumen 111 may be coated with a lubricious material, e.g., to facilitate distal and / or proximal movement of lead 104 within inner lumen 111.
[0036] Lead 104 may define an elongated body 120 (alternatively referred to herein as “lead body 120”) extending to lead distal end 126. Within elongated tube 110, elongated body 120 may be restrained to a collapsed configuration. For example, elongated tube 110 may inhibit elongated body 120 from forming one or more strain relief features along elongated body 120.
[0037] Lead 104 may include a fixation element 128 extending distally from lead distal end 126 of elongated body 120. Fixation element 128 may be configured to interface (e.g., penetrate) with tissue of the patient to affix fixation element 128 to the tissue. Fixation element 128 may include, but is not limited to, a fixation helix. In some examples, at least a portion of fixation element 128 may define an electrode. In such examples, system 100 may deliver electrical stimulation signals from an external signal generator (not pictured in FIG. 1 A) via the portion of fixation element 128 defining the electrode.
[0038] Lead 104 may define a first lead marker 124 and a second lead marker 122 on elongated body 120. Second lead marker 122 may be disposed on elongated body 120 at a more proximal position than first lead marker 124. First lead marker 124 and / or second lead marker 122 may perform additional functions. For example, first lead marker 124 and / or second lead marker 122 may be electrode(s). Lead 104 may include a third lead marker 125 at or around a proximal end of elongated body 120. When lead 104 is disposed within the patient body, third lead marker 125 may be positioned outside of the patient body.
[0039] When system 100 is in the retracted configuration, first lead marker 124 may be aligned with (e.g., may be longitudinally aligned with) first catheter marker 118A. The clinician may determine that fixation element 128 is entirely disposed within inner lumen 111 based on a visual identification that first lead marker 124 is aligned with first catheter marker 118A. First lead marker 124 and first catheter marker 118A may be collectively referred to herein as a “first marker pair”. When first lead marker 124 is aligned with first catheter marker 118A, second lead marker 122 may be aligned with another catheter marker 118 (e.g., with catheter marker 118D, alternatively referred to herein as “second catheter marker 118D”). Second lead marker 122 and second catheter marker 118D may be collectively referred to herein as a “second marker pair”. When first lead marker 124 is aligned with first catheter marker 118A, third lead marker 125 may be aligned within proximal catheter marker 118N. Third lead marker 125 and proximal catheter marker 118N may be collectively referred to as a “third marker pair”. In some examples, whenDocket No: A0013244W001 / 2222-639W001 fixation element 128 is entirely disposed within inner lumen 111, each of the first marker pair, second marker pair, and third marker pair are in alignment. In such examples, the clinician may determine the position of fixation element 128 within inner lumen 111 based on the alignment of one or more of the first marker pair, second marker pair, or the third marker pair, e.g., allowing the clinician to determine the position of fixation element 128 within inner lumen 111 in case one or more of the first or second marker pairs are obscured (e.g., by patient tissue).
[0040] Each of first lead marker 124, second lead marker 122, third lead marker 125 and catheter markers 118 may be visually distinctive. For example, each of first lead marker 124, second lead marker 122, and catheter markers 118 may be a different color, have a different texture, have a different label, have a different pattern, or the like. In some examples, each of first lead marker 124, second lead marker 122, and catheter markers 118 may have (e.g., a different) high-contrast color. High-contrast colors may include, but are not limited to, a bright green color, a bright blue color, or the like. The high-contrast colors may contrast first lead marker 124, second lead marker 122, and / or catheter markers 118 against tissue of the patient. The high-contrast colors may provide increased contrast against patient tissue, e.g., compared to other colors such as pink, red, purple, or the like. In some examples, first lead marker 124, second lead marker 122, and / or catheter markers 118 may be fluorescent (e.g., under a standard white light, under an ultraviolet (UV) light). First lead marker 124, second lead marker 122, and / or catheter markers 118 may be formed from a radiopaque material.
[0041] In some examples, as illustrated in FIG. 1, first catheter marker 118A, second catheter marker 118D, and proximal catheter marker 118N may be longer than one or more other catheter markers 118 (e.g., than catheter marker 118B). The clinician may distinguish first catheter marker 118A, second catheter 118D, and / or proximal catheter marker 118N from other catheter markers 118 based on the difference in length. Each of catheter markers 118 may include markings indicating a distance (e.g., from catheter distal end 116, from handle 106). The markings may include, but are not limited to, numbers, letters, symbols, characters, or the like. When the clinician advances delivery catheter 102 into the patient, the clinician may determine a length of delivery catheter 102 inserted into the patient based at least in part on alignment of catheter markers 118 with an indexing feature (e.g., with the skin of the patient, with a surface of an incision site on the patient, with a feature on an introducer, or the like).
[0042] FIG. IB is a conceptual diagram illustrating system 100 of FIG. 1 A in an advanced configuration. The clinician may advance lead 104 distally within delivery catheter 102 to advance fixation element 128 (e.g., and at least a distal portion of elongated body 120) out of inner lumen 111 of elongated tube 110. In the advanced configuration, fixation element 128 mayDocket No: A0013244W001 / 2222-639W001 be exposed outside of delivery catheter 102 and may engage with patient tissue to affix lead 104 to the tissue.
[0043] The clinician may control movement of lead 104 within delivery catheter 102 and determine a relative position of lead 104 within delivery catheter 102 based on the alignments of catheter markers 118 on delivery catheter 102 and lead markers (e.g., first lead marker 124, second lead marker 122) on lead 104. The clinician may transition system 100 from the retracted configuration to the advanced configuration by advancing lead 104 distally within delivery catheter 102 until first catheter marker 118A is aligned with second lead marker 122 on lead 104. When second lead marker 122 is aligned with first catheter marker 118A, fixation element 128 may be distal to catheter distal end 116 of delivery catheter 102. When fixation element 128 is distal to catheter distal end 116, fixation element 128 may be exposed outside of delivery catheter 102 and may engage with patient tissue to affix fixation element 128 to the patient tissue. First lead marker 124 and second lead marker 122 may have different colors, e.g., to allow the clinician to visually identify when second lead marker 122 is aligned with first catheter marker 118A.
[0044] In some examples, when first catheter marker 118A is aligned within second lead marker 122 on lead 104, a catheter marker 118 distal to proximal catheter marker 118N (alternatively referred to herein as “fourth catheter marker 118M”) is aligned with third lead marker 125 on lead 104. Fourth catheter marker 118M may be positioned outside of the patient body when delivery catheter 102 and lead 104 are inserted into the patient body. The clinician may determine that system 100 is in the advanced configuration based on one or more of the alignment of first catheter marker 118A with second lead marker 122 or the alignment of fourth catheter marker 118M with third lead marker 125. The clinician may use the alignment of fourth catheter marker 118M with third lead marker 125 to determine the position of fixation element 128 relative to catheter distal end 116, e.g., when first catheter marker 118A and second lead marker 122 are obscured.
[0045] FIG. 2 is a conceptual diagram illustrating an example implantable lead 104A (alternatively referred to herein as “lead 104A”). Lead 104A may be an example of lead 104 of system 100 of FIG. 1A. Lead 104 A may extend along longitudinal axis 201. Lead 104 may define a distal portion 202A and a proximal portion 202B. At least distal portion 202A of lead 104A may be configured to be inserted into delivery catheter 102.
[0046] Proximal portion 202B of lead 104 A may include at least a portion of elongated body 120, sleeve 204, and connector 206. Connector 206 may include one or more electrical contacts electrically coupled to one or more electrodes (e.g., to fixation element 128) on lead 104A.Connector 206 may be configured to be inserted into a port on an external signal generator toDocket No: A0013244W001 / 2222-639W001 electrically couple the one or more electrodes to the external signal generator. Connector 206 may be disposed at or around a proximal end of lead 104A. Sleeve 204 may be disposed around elongated body 120. Sleeve 204 may be positioned distal to connector 206. Sleeve 204 may define protrusion(s), recesses, surface texturing, shoulders, or the like. Sleeve 204 may provide a gripping surface on lead 104 A for the clinician and may facilitate advancement or withdrawal of lead 104A along longitudinal axis 201 by the clinician. Sleeve 204 may define a larger outer diameter than elongated body 120, e.g., to inhibit unintended over-insertion of lead 104A into delivery catheter 102.
[0047] Distal portion 202A may extend from proximal portion 202B to lead distal end 126. Distal portion 202A may define a strain relief feature 208. While FIG. 2 illustrates lead 104A with one strain relief feature 208, other examples of lead 104 A may include two or more strain relief features 208. When lead 104A is inserted into delivery catheter 102, elongated tube 110 of delivery catheter 102 may retain lead 104 A in a collapsed configuration and may inhibit lead 104A from forming strain relief feature 208. When lead 104A is outside of delivery catheter 102 (e.g., after implantation of lead 104 A and retraction of delivery catheter 102 from within the patient), lead 104 may be unconstrained and may define strain relief feature 208, e.g., as illustrated in FIG. 2.
[0048] Strain relief feature 208 may include two or more undulations 210 along elongated body 120. Elongated body 120 may be formed from a shape memory material (e.g., Nitinol, Carbothane), e.g., which may self-expand when unconstrained by delivery catheter 102 to define undulations 210. Undulations 210 may increase slack along a longitudinal length of elongated body 120 and may reduce tension on lead 104A (e.g., on fixation element 128) after implantation of lead 104A. The reduced tension may inhibit unintended movement and / or dislodgement of lead 104A within the patient. Strain relief feature 208 may be disposed at or around lead distal end 126 or proximal to lead distal end 126 (e.g., at or around first lead marker 124, between first lead marker 124 and second lead marker 122, at or around second lead marker 122, proximal to second lead marker 122).
[0049] FIG. 3 is a conceptual diagram illustrating another example of implantable lead 104B (alternatively referred to herein as “lead 104B”). Lead 104B may be an example of lead 104 of system 100 of FIG. 1 A and may be identical to lead 104 A previously described above, aside from the elements described herein. For example, distal portion 302A of lead 104B may be identical to distal portion 202A of lead 104A and proximal portion 302B of lead 104B may be identical to proximal portion 202B of lead 104A, aside from the elements described below.
[0050] Distal portion 302A of lead 104B may, when unconstrained by delivery catheter 102, define strain relief feature 304. For example, elongated body 120 may define strain relief featureDocket No: A0013244W001 / 2222-639W001 304 on distal portion 302A. Lead 104B may include strain relief feature 304 instead of or in addition to strain relief feature 208. Strain relief feature 304 may include one or more strain relief loops 306. Distal portion 302A of lead 104B may define a linear elongated shape when constrained by delivery catheter 102 and may self-expand to define strain relief loop 306 when unconstrained by delivery catheter 102.
[0051] Strain relief loop 306 may form at least one complete revolution. Strain relief loop 306 may apply a distal force on fixation element 128. The distal force may urge fixation element 128 further towards patient tissue and improve contact and / or fixation of fixation element 128 into the patient tissue. In some examples, as illustrated in FIG. 3, strain relief loop 306 may revolve in a counter-clockwise direction along a reference plane extending along longitudinal axis 201. Strain relief feature 304 may include one strain relief loop 306 with at least one complete revolution and / or two or more separate strain relief loops 306. Strain relief feature 304 may be disposed at one or more location along distal portion 302A.
[0052] Strain relief loop 306 may, when deployed, be oriented to hold an electrode on lead 104 (e.g., at, around or within first lead marker 124) against a tissue surface. A portion of lead 104 proximal to the electrode (e.g., proximal to first lead marker 124) may be raised off of and not contact the tissue surface. Strain relief loop 306 may apply radial forces (e.g., against the patient tissue) to anchor fixation element 128 radially within the patient tissue, e.g., inhibiting unintended rotation of fixation element 128 within the tissue.
[0053] In some examples, the clinician extends a specific length of lead 104B out of delivery catheter 102 to form strain relief loop 306. The exposure of the specific length of lead 104B out of delivery catheter 102 facilitates the transition of lead 104B to form strain relief loop 306. The clinician may determine that the specific length of lead 104B has been extended out of delivery catheter 102 based on alignment of a lead marker (e.g., proximal lead marker 125) with a catheter marker 118 (e.g., within second catheter marker 118D, with another catheter marker 118 distal to proximal catheter marker 118N).
[0054] FIG. 4 A is a conceptual diagram illustrating an example delivery catheter 102 A of system 100 of FIG. 1 A. FIG. 4B is a conceptual diagram illustrating an example delivery catheter 102B of system 100 of FIG. 1A. Delivery catheters 102 A, 102B may be examples of delivery catheter 100 of FIGS. 1A-1B. As illustrated in FIGS. 4A-4B, distal portion 114A of elongated tube 110 may extend along reference axis 402 and proximal portion 114B of elongated tube 110 may extend along reference axis 404. Reference axis 402 may be angled away from reference axis 404.
[0055] Reference axis 402 may be offset from reference axis 404 by angle 406. Angle 406 may be between about 20 degrees and about 60 degrees (e.g., about 35 degrees). Curved portionDocket No: A0013244W001 / 2222-639W001 112 of elongated tube 110 may define a curvature with an angle 408. Angle 408 may be complimentary to angle 406 and may be between about 120 degrees to about 160 degrees (e.g., about 145 degrees). The curvature of curved portion 112 between distal portion 114A and proximal portion 114B may allow catheter distal end 116 (e.g., distal end 116A of delivery catheter 102 A, distal end 116B of delivery catheter 102B) to be placed in contact with a tissue surface at a first angle (e.g., between about 20 degrees and about 60 degrees) while allowing proximal portion 114B to be oriented at a second angle (e.g., less than the first angle) relative to the tissue surface, e.g., compared to another delivery catheter without the curvature. The first angle may be the same as or different from angle 406.
[0056] Distal end 116 of delivery catheter 102 may be shaped to facilitate contact with the tissue surface at the first angle. In some examples, as illustrated in FIG. 4A, distal end 116A of delivery catheter 102 A defines a semi-spherical or rounded shape. In some examples, as illustrated in FIG. 4B, distal end 116B of delivery catheter 102B defines one or more angled surfaces. In such examples, distal end 116B may define a first surface 412 and a second surface 414 angled away from first surface 412. First surface 412 may be orthogonal to distal portion 114A (e.g., to reference axis 402). Second surface 414 may extend from an edge of first surface 412 to distal portion 114A. Second surface 414 may be angled from first surface 412 and / or distal portion 114A such that when distal end 116B contacts the tissue surface at the first angle, at least a portion of second surface 414 or an entirety of second surface 414 is in contact with the tissue surface. Distal end 116 of delivery catheter 102 may be tapered, e.g., to facilitate navigation of the delivery catheter 102 within the patient body. Distal end 116 of delivery catheter 102 may be formed from a more flexible material (e.g., with a lower durometer) than a more proximal portion of delivery catheter 102, e.g., to facilitate navigation of delivery catheter 102 within the patient. Distal end 116 of delivery catheter 102 may define an atraumatic tip.
[0057] FIG. 5 A is a conceptual diagram illustrating insertion of system 100 of any of FIGS.1A-4B within a patient. FIG. 5B is a conceptual diagram illustrating implantation of lead 104 of system 100 of any of FIGS. 1 A-4B within the patient. While FIGS. 5A-5B are illustrated with respect to implantation of lead 104 within pericardial cavity 506 of the patient, system 100 may be used to implant lead 104 at one or more other locations within the patient (e.g., within another body lumen of the patient). Delivery catheter 102 as illustrated in FIGS. 5A-5B may be delivery catheter 102 A, delivery catheter 102B, or any other examples of delivery catheter 102 as described herein.
[0058] The clinician may advance delivery catheter 102 containing lead 104 into pericardial cavity 506 of the patient. Pericardial cavity 506 may represent a space between pericardium 502 of the patient and epicardium 504 of the heart of the patient. When the clinician inserts deliveryDocket No: A0013244W001 / 2222-639W001 catheter 102 into pericardial cavity 506, the clinician may retain lead 104 entirely within inner lumen 111 of elongated tube 110 of delivery catheter 102. For example, the clinician may retain fixation element 128 within inner lumen 111 during insertion of elongated tube 110 into pericardial cavity 506.
[0059] The clinician may visually monitor and maintain an alignment between first catheter marker 118A and first lead marker 124 to retain fixation element 128 within inner lumen 111. The clinician may visually monitor first catheter marker 118A and first lead marker 124 through pericardium 502. First catheter marker 118A and first lead marker 124 may be visually identifiable and distinguishable through pericardium 502 and / or one or more other layers of patient tissue, e.g., under illumination (e.g., under white lighting, under UV lighting). First catheter marker 118A and first lead marker 124 may have a high-contrast color or a fluorescent color, e.g., to facilitate visualization through one or more tissue layers of the patient (e.g., through pericardium 502).
[0060] The clinician may insert delivery catheter 102 into pericardial cavity 506 in the orientation illustrated in FIG. 5A, e.g., with distal portion 114A of elongated tube 110 extending towards outer surface 508 of epicardium 504. In some examples, the clinician inserts delivery catheter 102 into pericardial cavity 506 in a reduced-profile orientation. In the reduced-profile orientation, delivery catheter 102 may be rotated (e.g., by up to 90 degrees about reference axis 404 of FIGS. 4A-4B), e.g., such that distal portion 114A of elongated tube 110 is oriented along a reference plane parallel to outer surface 508 of epicardium 504. Once delivery catheter 102 is within pericardial cavity 506, the clinician may rotate delivery catheter 102 (e.g., about reference axis 404 of FIGS. 4A-4B) to point distal portion 114A and catheter distal end 116 towards outer surface 508, e.g., as illustrated in FIG. 5A.
[0061] In the orientation illustrated in FIG. 5 A, at least a portion of delivery catheter 102 may contact outer surface 503 of pericardium 502. For example, at least a portion of curve portion 112 of elongated tube 110 and / or of proximal portion 114B of elongated tube 110 may contact outer surface 503. Delivery catheter 102 may contact outer surface 503 of pericardium 502 while catheter distal end 116 contacts outer surface 508 of epicardium 504. The contact between delivery catheter 102 and pericardium 502 may expand pericardial cavity 506 and increase a volume of space between pericardium 502 and epicardium 504, e.g., available for the implantation of lead 104. When delivery catheter 102 contacts outer surface 503 of pericardium 502, pericardium 502 may assert reactive forces on delivery catheter 102, e.g., to urge catheter distal end 116 and distal portion 114A further towards outer surface 508 of epicardium 504. Urging catheter distal end 116 and distal portion 114A towards outer surface 508 may improveDocket No: A0013244W001 / 2222-639W001 contact between catheter distal end 116 and outer surface 508, e.g., thereby improving contact between lead 104 and outer surface 508 during implantation.
[0062] Once the clinician places catheter distal end 116 in contact with outer surface 508 of epicardium 504, the clinician may puncture outer surface 508 with fixation element 128 and affix fixation element 128 within epicardium 504. In some examples, the clinician advances lead 104 within delivery catheter 102 until second lead marker 122 is aligned with first catheter marker 118A. The clinician may then rotate lead 104 within delivery catheter 102 until fixation element 128 penetrates outer surface 508 and is advanced into epicardium 504. In some examples, once the clinician places catheter distal end 116 in contact with outer surface 508, the clinician may rotate lead 104 within delivery catheter 102 until second lead marker 122 becomes aligned with first catheter marker 118A. As fixation element 128 (e.g., a fixation helix) is rotated within epicardium 504, fixation element 128 may translate a rotary force into a linear force and further advance fixation element 128 within epicardium 504.
[0063] During advancement of fixation element 128 into epicardium 504, delivery catheter 102 may continue to maintain contact with outer surface 503 of pericardium 502 and with outer surface 508 of epicardium 504, e.g., to cause fixation element 128 and / or catheter distal end 116 to maintain contact with epicardium 504 and facilitate advancement of fixation element 128 into epicardium 504.
[0064] FIG. 6 is a flow chart illustrating an example process of implanting an implantable lead 104 using system 100 of any of FIGS. 1-5B. While FIG. 6 is primarily described herein with respect to implantation of lead 104 within pericardial cavity 506 of the patient, the techniques described herein may be implemented to implant lead 104 at one or more other locations on the patient (e.g., within a blood vessel or another body lumen of the patient).
[0065] A clinician may insert implantable lead 104 into inner lumen 111 of delivery catheter 102 (602). Inner lumen 111 may extend along elongated tube 110 of delivery catheter 102 from proximal opening 108 to catheter distal end 116. Elongated tube 110 may define distal portion 114 A, proximal portion 114B, and curved portion 112 extending from proximal portion 114B to distal portion 114A. Curved portion 112 may define one or more curvatures along the length of elongated tube 110. Inner lumen 111 may extend through distal portion 114A, proximal portion 114B, and curved portion 112.
[0066] The clinician may insert lead distal end of lead 104 into inner lumen 111 and advance lead 104 within inner lumen 111. The clinician may advance lead 104 until first lead marker 124 on lead 104 is aligned with (e.g., is overlapping with, has aligned edges with) first catheter marker 118A. When first lead marker 124 is aligned with first catheter marker 118A, lead distal end 126 and fixation element 128 extending from lead distal end 126 may be wholly disposedDocket No: A0013244W001 / 2222-639W001 within inner lumen 111 (e.g., proximal or flush with catheter distal end 116). First catheter marker 118A, first lead marker 124, any other catheter markers (e.g., catheter markers 118), and / or any other lead markers (e.g., second lead marker 122) may be visually distinct to allow the clinician to visually determine when first catheter marker 118A is aligned with first lead marker 124.
[0067] The clinician may insert delivery catheter 102 into body of a patient to a target location (604). The target location may be located within, but is not limited to, pericardial cavity 506 of the patient. The clinician may access pericardial cavity 506 via a sub-ziphoid insertion or a mini -thoracotomy procedure. The clinician may monitor the insertion of delivery catheter 102 via one or more visualization techniques including, but is not limited to, via a thoracoscope. The clinician may insert delivery catheter 102 into pericardial cavity 506 and may monitor the position and / or orientation of delivery catheter 102 within pericardial cavity 506 through pericardium 502 of the patient (e.g., under white lighting, under UV lighting). The clinician may monitor the position and / or orientation of delivery catheter 102 based on the positions and / or orientations of catheter distal end 116 and / or one or more lead and / or catheter markers (e.g., first catheter marker 118A, first lead marker 124, second lead marker 122).
[0068] During insertion of delivery catheter 102 to the target location, the clinician may retain lead 104 within delivery catheter 102 (e.g., may retain fixation element 128 entirely within inner lumen 111 of delivery catheter 102). The clinician may keep first lead marker 124 in alignment with first catheter marker 118A to continue to retain lead 104 within delivery catheter 102. When the clinician inserts delivery catheter 102 into pericardial cavity 506, the clinician may continue to visually monitor the alignment of first lead marker 124 and first catheter marker 118A through pericardium 102. First lead marker 124 and first catheter marker 118A may have a high-contrast color, may be fluorescent, and / or may be radiopaque, e.g., to allow the clinician to identify first lead marker 124 and first catheter marker 118A through pericardium 502 and / or one or more other layers of patient tissue.
[0069] The clinician may place catheter distal end 116 of delivery catheter 102 in contact with tissue of the patient (606). The tissue of the patient may be epicardium 504 of the patient. In some examples, the clinician inserts delivery catheter 102 into pericardial cavity 506 in a reduced-profile orientation (e.g., with distal portion 114A of elongated tube 110 extending along a reference plane parallel to outer surface 508 of epicardium 504). In such examples, the clinician may rotate delivery catheter 102 within pericardial cavity 506 to point distal portion 114A towards outer surface 508 and place catheter distal end 116 of delivery catheter 102 in contact with outer surface 508. In some examples, the clinician inserts delivery catheter 102 into pericardial cavity 506 with distal portion 114A oriented to point towards outer surface 508. TheDocket No: A0013244W001 / 2222-639W001 clinician may adjust the position and / or orientation of delivery catheter 102 until catheter distal end 116 is in contact with outer surface 508 of epicardium 504 at a target location.
[0070] When delivery catheter 102 is within pericardial cavity 506, the curvature along curve portion 112 of delivery catheter 102 may allow catheter distal end 116 to be placed in contact with outer surface 508 at an angle, e.g., within the space between pericardium 502 and epicardium 504. A portion of delivery catheter 102 (e.g., a portion of proximal portion 114B and / or of curved portion 12) may contact outer surface 503 of pericardium 502 while catheter distal end 116 contacts outer surface 508 of epicardium 504. The contact between delivery catheter 102 and pericardium 502 may further urge catheter distal end 116 towards outer surface 508, e.g., increasing contact between catheter distal end 116 and epicardium 504.
[0071] The clinician may affix implantable lead 104 within tissue of the patient (608). The clinician may rotate lead 104 within delivery catheter 102 to advance fixation element 128 into the tissue. Fixation element 128 may define a fixation helix and may translate a rotary force on fixation element 128 to advance fixation element 128 into the tissue. The clinician may continue to rotate lead 104 until second lead marker 122 is aligned with first catheter marker 118A.Alignment of second lead marker 122 with first catheter marker 118A may indicate that fixation element 128 is affixed to a threshold depth within epicardium 504. The clinician may visually identify the locations of first catheter marker 118A and second lead marker 122 (e.g., through pericardium 502) to determine whether first catheter marker 118A is aligned with second lead marker 122. First lead marker 124 and second lead marker 122 may be visually distinct, e.g., to facilitate differentiation by the clinician between first lead marker 124 and second lead marker 122.
[0072] The clinician may retract delivery catheter 102 from within the body of the patient (610). The clinician may rotate delivery catheter 102 (e.g., into the reduced-profile orientation) after implantation of lead 104. The clinician may then retract delivery catheter 102 (e.g., from within pericardial cavity 506) in the reduced-profile orientation. As the clinician retracts delivery catheter 102, elongated tube 110 may be retracted from around the implanted lead 104. As elongated body 120 of lead 104 is exposed within the body of the patient, portions of elongated body 120 may self-expand and define one or more strain relief features (e.g., strain relief feature 208, strain relief feature 304). The one or more strain relief features may reduce tension on lead 104 (e.g., during retraction of delivery catheter 102 from around lead 104, e.g., thereby inhibiting unintended dislodgement of fixation element 128 of lead 104 from the tissue (e.g., from epicardium 504). The one or more strain relief features may define, but are not limited to, undulation(s) 210 and / or strain relief loop(s) 306. The one or more strain relief features may urgeDocket No: A0013244W001 / 2222-639W001 fixation element 128 further towards the tissue, e.g., thereby improving fixation of lead 104 to the tissue.
[0073] Once delivery catheter 102 is retracted, the clinician may couple lead 104 to an external signal generator, e.g., by inserting connector 206 of lead 104 into a corresponding port on the external signal generator. Lead 104 may deliver an electrical stimulation signal (e.g., a cardiac pacing signal, a cardiac shock signal) to cardiac tissue of the patient (e.g., epicardium 504 of the patient) via one or more electrodes on lead 104. Fixation element 128 may define an electrode (e.g., a helical electrode) and may deliver the electrical stimulation signal from the external signal generator to the cardiac tissue.
[0074] This disclosure describes the following examples:
[0075] Example 1: a system comprising: a delivery catheter comprising: an elongated tube, the elongated tube defining an inner lumen extending along a longitudinal length of the elongated tube to a catheter distal end of the elongated tube; and a catheter marker disposed at a longitudinal position of the elongated tube; and an implantable lead configured to be disposed within the delivery catheter, the implantable lead comprising: an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient; a first lead marker disposed at a first longitudinal location of the elongated body; and a second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location being proximal to the first longitudinal location, wherein the catheter marker, the first lead marker, and the second lead marker are configured to be disposed within a body of a patient during implantation of the implantable lead in the body of the patient, wherein when the first lead marker is longitudinally aligned with the catheter marker, the fixation element is disposed within the inner lumen of the elongated tube of the delivery catheter, and wherein when the second lead marker is longitudinally aligned with the catheter marker, the fixation element extends distally past the catheter distal end of the elongated tube.
[0076] Example 2: the system of example 1, wherein the fixation element comprises a fixation helix.
[0077] Example 3: the system of any of examples 1 and 2, wherein the fixation element comprises an electrode of the implantable lead.
[0078] Example 4: the system of any of examples 1-3, wherein the elongated tube is formed from a transparent material.
[0079] Example 5: the system of any of examples 1-3, wherein the elongated tube comprises: a proximal portion extending along a catheter longitudinal axis; and a distal portion connected toDocket No: A0013244W001 / 2222-639W001 the proximal portion and extending distally and radially away from the catheter longitudinal axis, wherein the distal portion of the elongated tube defines the catheter distal end.
[0080] Example 6: the system of example 5, wherein the elongated tube comprises a curved portion extending between the proximal portion and the distal portion, and wherein the curved portion defines an angle between about 20 degrees to about 60 degrees.
[0081] Example 7: the system of example 6, wherein the angle is about 35 degrees.
[0082] Example 8: the system of any of examples 5-7, wherein the tissue comprises a first tissue, wherein when at least a portion of the delivery catheter is inserted between a first tissue and a second tissue, one or more of the curved portion or the proximal portion is configured to contact the second tissue to urge the catheter distal end towards contact with the first tissue.
[0083] Example 9: the system of example 8, wherein the at least the portion of the delivery catheter is configured to be inserted into a pericardial cavity of the patient, wherein the first tissue comprises an epicardium of the patient, and wherein the second tissue comprises a pericardium of the patient.
[0084] Example 10: the system of any of examples 1-9, wherein the implantable lead is configured to be advanced or retracted within the inner lumen of the elongated tube of the delivery catheter.
[0085] Example 11 : the system of any of examples 1-10, wherein each of the catheter marker, the first lead marker, and the second lead marker defines one or more of a unique color, unique texture, or unique pattern than every other marker of the catheter marker the first lead marker, and the second lead marker.
[0086] Example 12: the system of any of examples 1-11, wherein the catheter distal end defines a radiopaque tip.
[0087] Example 13: the system of any of examples 1-12, wherein the catheter marker, the first lead marker, and the second lead marker are visually distinguishable through a layer of translucent tissue of the patient.
[0088] Example 14: the system of any of examples 1-13, wherein one or more of the catheter marker, the first lead marker, or the second lead marker has a high contrast color.
[0089] Example 15: the system of any of examples 1-14, wherein one or more of the catheter marker, the first lead marker, or the second lead marker is fluorescent.
[0090] Example 16: the system of any of examples 1-15, wherein the elongated body defines one or more strain relief features.
[0091] Example 17: the system of example 16, wherein the one or more strain relief features comprises one or more undulations along the elongated body.Docket No: A0013244W001 / 2222-639W001
[0092] Example 18: the system of any of examples 16 and 17, wherein the one or more strain relief features comprises one or more loops formed by the elongated body.
[0093] Example 19: the system of any of examples 16-18, wherein the one or more strain relief features are configured to urge the fixation element distally along the longitudinal axis.
[0094] Example 20: the system of any of examples 1-19, wherein when the first lead marker is longitudinally aligned with the catheter marker, a distal end of the fixation element is disposed within the inner lumen and adjacent to the catheter distal end of the elongated tube.
[0095] Example 21 : a delivery catheter comprising: an elongated tube comprising: a proximal portion extending along a longitudinal axis; a distal portion extending radially away from the longitudinal axis; and a curved portion connecting the proximal portion to the distal portion; and one or more catheter markers disposed at a longitudinal position of the elongated tube, wherein the curved portion defines a curvature in the elongated tube along a reference plane extending along the longitudinal axis.
[0096] Example 22: the delivery catheter of example 21, wherein the elongated tube is formed from a transparent material.
[0097] Example 23: the delivery catheter of any of examples 21 and 22, wherein the curved portion defines an angle between a first reference axis of the proximal portion and a second reference axis of the distal portion, and wherein the angle is between about 20 degrees and about 60 degrees.
[0098] Example 24: the delivery catheter of example 23, wherein the angle is about 35 degrees.
[0099] Example 25: the delivery of any of examples 21-24, wherein when at least a portion of the delivery catheter is inserted into a space between a first tissue and a second tissue of a patient, one or more of the curved portion or the proximal portion is configured to contact the second tissue to urge the catheter distal end towards contact with the first tissue.
[0100] Example 26: the delivery catheter of example 25, wherein the at least the portion of the delivery catheter is configured to be inserted into a pericardial cavity of the patient, wherein the first tissue comprises an epicardium of the patient, and wherein the second tissue comprises a pericardium of the patient.
[0101] Example 27: the delivery catheter of any of examples 21-26, wherein the elongated tube defines an inner lumen configured to retain an implantable lead, and wherein the one or more catheter markers are configured to be aligned with corresponding lead markers on the implantable lead to indicate a position of a fixation element of the implantable lead relative to a distal end of the elongated tube.Docket No: A0013244W001 / 2222-639W001
[0102] Example 28: the delivery catheter of example 27, wherein when a first catheter marker of the one or more catheter markers is longitudinally aligned with a first lead marker on the implantable lead, a distal end of the fixation element is disposed within the inner lumen and adjacent to the distal end of the elongated tube.
[0103] Example 29: the delivery catheter of any of examples 21-28, wherein the distal portion defines a catheter distal end, and wherein the catheter distal end comprises a radiopaque tip.
[0104] Example 30: the delivery catheter of any of examples 21-29, wherein the one or more catheter markers are visually identifiable through a layer of translucent tissue.
[0105] Example 31 : the delivery catheter of any of examples 21-30, wherein the one or more catheter markers has a high contrast color.
[0106] Example 32: the delivery catheter of any of examples 21-31, wherein the one or more catheter markers are fluorescent.
[0107] Example 33: an implantable lead comprising: an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient; a first lead marker disposed at a first longitudinal location of the elongated body; and a second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location being proximal to the first location along the longitudinal axis, wherein the elongated body defines one or more strain relief features along a longitudinal length of the elongated body, wherein the first lead marker is configured to indicate, when aligned with a catheter marker on a delivery catheter, that the fixation element is disposed within the delivery catheter, and wherein the second lead marker is configured to indicate, when aligned with the catheter marker, that at least the fixation element of the implantable lead protrudes from a distal end of the delivery catheter.
[0108] Example 34: the implantable lead of example 33, wherein the fixation element comprises a fixation helix.
[0109] Example 35: the implantable lead of any of examples 33 and 34, wherein the fixation element comprises an electrode of the implantable lead.
[0110] Example 36: the implantable lead of any of examples 33-35, wherein each of the first lead marker and the second lead marker defines one or more of: a unique color; a unique texture; or a unique pattern.
[0111] Example 37: the implantable lead of any of examples 33-36, wherein each of the first lead marker or the second lead marker is visually distinguishable through a layer of translucent tissue of the patient.Docket No: A0013244W001 / 2222-639W001
[0112] Example 38: the implantable lead of any of examples 33-37, wherein one or more of the first lead marker or the second lead marker has a high contrast color.
[0113] Example 39: the implantable lead of any of examples 33-38, wherein one or more of the first lead marker or the second lead marker is fluorescent.
[0114] Example 40: the implantable lead of any of examples 33-39, wherein the one or more strain relief features comprises one or more undulations along the longitudinal length of the elongated body.
[0115] Example 41 : the implantable lead of any of examples 33-40, wherein the one or more strain relief features comprises one or more loops formed by the elongated body.
[0116] Example 42: the implantable lead of any of examples 33-41, wherein the one or more strain relief features are configured to urge the fixation element distally along the longitudinal axis.
[0117] Example 43: a method comprising: advancing a medical device system to a target location within a patient, the medical device system comprising: a delivery catheter comprising: an elongated tube, the elongated tube defining an inner lumen extending along a longitudinal length of the elongated tube to a catheter distal end of the elongated tube; and a catheter marker disposed at a longitudinal position of the elongated tube; and an implantable lead configured disposed within the inner lumen, the implantable lead comprising: an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient; a first lead marker disposed at a first longitudinal location of the elongated body; and a second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location being proximal to the first longitudinal location; placing the catheter distal end of the elongated tube in contact with a tissue of the patient, wherein during placement of the catheter distal end, the first lead marker is aligned with the catheter marker to retain the fixation element within the inner lumen of the elongated tube; advancing the implantable lead within the inner lumen until the second lead marker is aligned with the catheter marker to place the fixation element in contact with the tissue of the patient; affixing the fixation element of the implantable lead to the tissue of the patient; and retracting the delivery catheter from within the patient.
[0118] Example 44: the method of example 43, wherein the fixation element comprises a fixation helix, and wherein affixing the fixation element of the implantable lead to the tissue comprises: rotating the implantable lead about the longitudinal axis to cause the fixation element to penetrate a surface of the tissue.Docket No: A0013244W001 / 2222-639W001
[0119] Example 45: the method of any of examples 43 and 44, wherein the fixation element comprises an electrode of the implantable lead.
[0120] Example 46: the method of any of examples 43-45, wherein the elongated tube comprises a proximal portion extending along a catheter longitudinal axis; a distal portion connected to the proximal portion and extending distally and radially away from the catheter longitudinal axis, wherein the distal portion of the elongated tube defines the catheter distal end; and a curved portion extending between the proximal portion and the distal portion.
[0121] Example 47: the method of example 46, wherein the curved portion defines an angle between about 20 degrees to about 60 degrees.
[0122] Example 48: the method of any of examples 44-47, wherein the target location is within a pericardial cavity of the patient, wherein the tissue comprises an epicardium of the patient, and wherein placing the catheter distal end of the elongated tube in contact with the tissue of the patient comprises: placing one or more of the curved portion or the proximal portion in contact with a pericardium of the patient to urge the catheter distal end towards contact with the epicardium.
[0123] Example 49: the method of any of examples 44-48, wherein each of the catheter marker, the first lead marker, and the second lead marker defines one or more of a unique color, unique texture, or unique pattern than every other marker of the catheter marker the first lead marker, and the second lead marker.
[0124] Example 50: the method of any of examples 44-49, wherein the catheter distal end defines a radiopaque tip.
[0125] Example 51 : the method of any of examples 44-50, wherein the catheter marker, the first lead marker, and the second lead marker are visually distinguishable through a layer of translucent tissue of the patient.
[0126] Example 52: the method of any of examples 44-51, wherein one or more of the catheter marker, the first lead marker, or the second lead marker has a high contrast color.
[0127] Example 53: the method of any of examples 44-52, wherein one or more of the catheter marker, the first lead marker, or the second lead marker is fluorescent.
[0128] Example 54: the method of any of examples 44-53, wherein the elongated body defines one or more strain relief features.
[0129] Example 55: the method of example 54, wherein the one or more strain relief features comprises one or more undulations along the elongated body.
[0130] Example 56: the method of any of examples 54 and 55, wherein the one or more strain relief features comprises one or more loops formed by the elongated body.Docket No: A0013244W001 / 2222-639W001
[0131] Example 57: the method of any of examples 54-56, wherein the one or more strain relief features are configured to urge the fixation element distally along the longitudinal axis.
[0132] Various examples of the disclosure have been described. Any combination of the described systems, operations, or functions is contemplated. These and other examples are within the scope of the following claims.
Claims
Docket No: A0013244W001 / 2222-639W001 WHAT IS CLAIMED IS:
1. A system comprising:a delivery catheter comprising:an elongated tube, the elongated tube defining an inner lumen extending along a longitudinal length of the elongated tube to a catheter distal end of the elongated tube; anda catheter marker disposed at a longitudinal position of the elongated tube; and an implantable lead configured to be disposed within the delivery catheter, the implantable lead comprising:an elongated body extending along a longitudinal axis to a lead distal end; a fixation element extending distally from the lead distal end of the elongated body, the fixation element being configured to affix the implantable lead to tissue of a patient;a first lead marker disposed at a first longitudinal location of the elongated body; anda second lead marker disposed at a second longitudinal location of the elongated body, the second longitudinal location being proximal to the first longitudinal location,wherein the catheter marker, the first lead marker, and the second lead marker are configured to be disposed within a body of a patient during implantation of the implantable lead in the body of the patient, wherein when the first lead marker is longitudinally aligned with the catheter marker, the fixation element is disposed within the inner lumen of the elongated tube of the delivery catheter, and wherein when the second lead marker is longitudinally aligned with the catheter marker, the fixation element extends distally past the catheter distal end of the elongated tube.
2. The system of claim 1, wherein the fixation element comprises a fixation helix.
3. The system of any of claims 1 and 2, wherein the fixation element comprises an electrode of the implantable lead.
4. The system of any of claims 1-3, wherein the elongated tube is formed from a transparent material.Docket No: A0013244W001 / 2222-639W001 5. The system of any of claims 1-3, wherein the elongated tube comprises:a proximal portion extending along a catheter longitudinal axis; anda distal portion connected to the proximal portion and extending distally and radially away from the catheter longitudinal axis, wherein the distal portion of the elongated tube defines the catheter distal end.
6. The system of claim 5, wherein the elongated tube comprises a curved portion extending between the proximal portion and the distal portion, and wherein the curved portion defines an angle between about 20 degrees to about 60 degrees.
7. The system of any of claims 5-6, wherein the tissue comprises a first tissue, wherein when at least a portion of the delivery catheter is inserted between a first tissue and a second tissue, one or more of the curved portion or the proximal portion is configured to contact the second tissue to urge the catheter distal end towards contact with the first tissue.
8. The system of claim 7, wherein the at least the portion of the delivery catheter is configured to be inserted into a pericardial cavity of the patient, wherein the first tissue comprises an epicardium of the patient, and wherein the second tissue comprises a pericardium of the patient.
9. The system of any of claims 1-8, wherein the implantable lead is configured to be advanced or retracted within the inner lumen of the elongated tube of the delivery catheter.
10. The system of any of claims 1-9, wherein the catheter marker, the first lead marker, and the second lead marker are visually distinguishable through a layer of translucent tissue of the patient.
11. The system of any of claims 1-10, wherein one or more of the catheter marker, the first lead marker, or the second lead marker has a high contrast color.
12. The system of any of claims 1-11, wherein one or more of the catheter marker, the first lead marker, or the second lead marker is fluorescent.
13. The system of any of claims 1-12, wherein the elongated body defines one or more strain relief features.Docket No: A0013244W001 / 2222-639W00114. The system of claim 13, wherein the one or more strain relief features comprises one or more loops formed by the elongated body.
15. The system of any of claims 1-14, wherein when the first lead marker is longitudinally aligned with the catheter marker, a distal end of the fixation element is disposed within the inner lumen and adjacent to the catheter distal end of the elongated tube.
